HIV Learning Proficiencies Included in the HIV Primary Care Training Platform (Created on January 23, 2013) Foundation
Provider Stage 1
Provider Stage 1 Part 2
Provider Stage 1 Part 2 (cont.)
1.
PART 1
18. Recognize and Manage Immune Reconstitution Syndrome. 19. Identify and Manage Latent TB Infection. 20. Manage Hepatitis B Co-‐Infection. 21. Manage Herpes Simplex (Mucocutaneous) Co-‐Infection. 22. Manage Herpes Zoster Co-‐Infection. 23. Manage Candidiasis (Oral and Esophageal). 24. Manage Bacterial Respiratory Disease. 25. Recognize and Manage Common Gastrointestinal Infections. 26. Treat Common Dermatologic Conditions in HIV patients. 27. Assess and Manage Pain and Peripheral Neuropathy. 28. Screen For and Treat Common STIs: Syphilis, Gonorrhea, Chlamydia, and Genital Herpes. 29. Assess Substance Use/Abuse. 30. Provide Smoking Cessation Counseling and Care. 31. Identify and Mange Mental Health Co-‐ Morbidities: Anxiety/Panic Disorders, Depression, and Insomnia. 32. Assess Substance Use/Abuse. 33. Assess and Mange or Refer Common Oral Health Complaints.
Provide Preventive Reproductive Health Care to HIV-‐Positive Women
Explain the Natural History of HIV Disease to Patients and Families (HIV 101). Define Current Trends in the Epidemiology of HIV Infection in the United States. Integrate HIV Quality Improvement Measures into Patient Monitoring and Care. Optimize Clinic Management to Address Health Needs of HIV-‐ Positive Patients. Adhere to Principles of Confidentiality and HIPAA Regulations Specific to HIV-‐ Positive Patients. Provide HIV Testing in Accordance with CDC Recommendations and State/Local Regulations. Provide Timely Linkage to Care and Treatment for Newly Diagnosed HIV Patients. Provide Culturally Appropriate Patient Education and Care to HIV-‐Positive Patients. Provide a Supportive Care Environment for HIV-‐Positive Patients. Recognize and Address Common Stigma-‐Associated Barriers Encountered by HIV-‐ Positive Patients. Elicit a “Stigma-‐Free” Sexual History as Part of Comprehensive HIV Risk Assessment. Provide Comprehensive “Prevention with Positives” Education. Assess Eligibility for PrEP According to CDC Criteria
2. 3. 4. 5.
6.
7. 8. 9. 10.
11.
12. 13.
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17.
Perform Baseline History & Physical Examination on Newly Diagnosed HIV-‐Positive Patients. Appropriately Order and Interpret Baseline HIV-‐Related Lab Tests. Appropriately Order and Interpret HLA-‐B*5701 Test. Appropriately Order and Interpret HIV Genotype Test. Provide Appropriate Immunizations. Initiate and Monitor Ol Prophylaxis. Identify Need for and Readiness to Begin ARV Treatment (Includes CDC Staging). Prescribe and Manage First-‐Line Antiretroviral (ARV) Regimens with Consideration of Risk/Benefit, and Appropriateness Individualized for Each Patient. Monitor Disease Progression and Response to ARV Therapy. Manage Side Effects and Adverse Events Associated with ARV Regimen. Identify and Manage ARV Drug-‐Drug Interactions. Identify First-‐Line ARV Treatment Failure. Appropriately Switch ARV Regimens due to Toxicity or Side Effects. Assess/Monitor/Counsel Adherence with Medications, Appointments, and Referrals. Assess and Manage Common Complaints in the HIV-‐Positive Patient. Diagnose and Mange Acute Retroviral Syndrome. Appropriately Treat Occupational and Non-‐Occupational Post-‐ Exposure Prophylaxis.
34. Recognize Special Issues and Care and Treatment Needs of HIV-‐Positive Women Through the Life Cycle. 35. Perform Screening PAP Smear. 36. Appropriately Manage Abnormal PAP Smear Results in HIV-‐Positive Women. 37. Identify and Treat Common Vulvo-‐ Vaginal Infections and Inflammatory Conditions in HIV-‐Infected Women. 38. Recognize and Treat Pelvic Inflammatory Disease in HIV-‐Positive Women. 39. Provide Pre-‐Conception Counseling to HIV-‐Positive Women of Reproductive Age to Identify Reproductive Intentions/Promote Safe Conception. 40. Provide Effective Contraceptive Management/Assess Medical Eligibility for Use of Hormonal Contraceptive Agents in HIV-‐Positive Women. 41. Identify Special Considerations for Antiretroviral Use in HIV-‐Positive Women. 42. Consider Drug-‐Drug Interactions in Selection of Appropriate Hormonal Contraceptive in HIV-‐Positive Women on ART